Русский
Nederlandse taal
Deutsch
Francés
한국어
Português
Español
日本語
ไทย
Body Mesotherapy Near Me
Ingredient: 12mg/ml Micro cross-linked Hyaluronic Acid, Amino acids, Carnosine, Vitamin B2, Lidocaine hydrochloride
Specification: 1.5ml, 2ml
Package: Single package, Sterile
Application Area: Neck
Product Introduction：
The advanced micro-crosslinking technology allows sodium hyaluronate to provide longer hydration retention and a more even application, effectively reducing fine lines. Smooths neck lines, lifts and firms the skin, and enhances neck elasticity. Specially designed for neck filling, it helps reduce fine lines while allowing time for collagen fibers to form.
Product Display：
Product Details:
Type | |
Specification | 1.5ml, 2ml |
Ingredients | Micro cross linked sodium hyaluronic 12mg/ml, amino acids, carnosine, vitamin B2, lidocaine hydrochloride |
Application | Fill in the fine lines in the dermis |
Function | Smooth neck lines, lift and tighten, enhance neck elasticity |
Package | Single package, Sterile |
Storage | Room temperature (1-25ºC), cool and dry place |
Recommended | 1pc/time |
Recommended interval | 2-3 months/time, 3 times a course |
Product Package:
Customer Feedback：
Raw Material Advantages：
1. Lifts and tightens the neck, softens fine lines, and improves skin elasticity. Designed to smooth wrinkles and support collagen formation for a more youthful appearance.
2. Formulated with high sodium hyaluronate content for superior and long-lasting results. The exclusive micro-crosslinked technology prevents surface bumps, smooths wrinkles, and ensures a lasting effect. Lidocaine enhances the application experience.
Development Process:
Company Introduction:
Leveraging a solid 15-year track record in polysaccharide modification and crosslinking, our medical-grade material modification platform converts chitosan into carboxymethyl chitosan—reflected in our commercially available surgical anti-adhesion fluid—and modifies sodium hyaluronate into crosslinked sodium hyaluronate by employing sophisticated biphasic, monophasic, and micro-crosslinking strategies, while our microsphere production capabilities extend to creating crosslinked starch microspheres (as formulated in our composite microporous polysaccharide hemostatic powder) and innovative injectable microspheres of PCL, PLLA, and PMMA.
